SearchDictionaryMobileLogin

Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.

AbstractOBJECTIVE: Identification of prognostic factors for survival in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is necessary for appropriate monitoring, interventions, and timely referral for lung transplantation. Our objectives were (1) to identify factors associated with survival in SSc-PAH and (2) to evaluate the methodologic quality of prognostic studies against current standards. METHODS: A systematic review was performed to identify studies evaluating factors associated with survival in SSc-PAH. The methodologic quality of each study was evaluated using a methodologic quality index. RESULTS: HLA-DRw6 (RR 54.52, p = 0.01), HLA-DRw52 (RR not reported, p = 0.02), initial systolic pulmonary artery pressure (sPAP) > 60 mmHg (HR 3.60, 95% CI 1.42, 9.15), elevated mean right atrial pressure (mRAP) (HR 20.7, p = 0.0001), and shorter time between SSc onset and observed PAH (5.24 vs 9.93 yrs, p < 0.01) were associated with decreased survival. Age > 50 years (HR 2.34, 95% CI 0.54, 10.2), male sex (HR 2.02, 95% CI 0.65, 6.20), limited subtype (HR 2.37, 95% CI 0.68, 8.20), pulmonary fibrosis [Kaplan-Meier (KM) curves, p = 0.3], change in pulmonary vascular resistance (KM curves, p = 0.8), anti-centromere (HR 1.67, 95% CI 0.66, 4.26) and anti-ScL-70 (HR 0.28, 95% CI 0.03, 1.99) antibodies were not definitively associated with survival. Attributes of participants, prognostic factors, and outcome measures were well reported. Study attrition, confounding, and analysis were not well reported. CONCLUSION: HLA-DRw52 and -DRw6, initial sPAP > 60 mmHg, mRAP, and shorter time between SSc onset and observed PAH were associated with decreased survival; however, methodologic quality of study reporting was variable. Prognostic factor research is needed using current methodologic standards.
AuthorsSindhu R Johnson, John R Swinton, John T Granton (Affiliation: University Health Network, University of Toronto, Toronto, ON, Canada.)
JournalThe Journal of rheumatology (J Rheumatol) Vol. 35 Issue 8 Pg. 1584-90 (Aug 2008) ISSN: 0315-162X Canada
PMID18597400 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • HLA-DR Antigens
  • HLA-DR6 Antigen
  • HLA-DRw52
Topics
  • Age Factors
  • Female
  • Genetic Predisposition to Disease
  • HLA-DR Antigens (genetics)
  • HLA-DR6 Antigen (genetics)
  • Humans
  • Hypertension, Pulmonary (complications, genetics, mortality)
  • Male
  • Prognosis
  • Pulmonary Artery
  • Scleroderma, Systemic (complications, genetics, mortality)
  • Sex Factors
  • Survival Analysis